John G Ullman & Associates Inc. Reduces Holdings in Azenta, Inc. (NASDAQ:AZTA)

John G Ullman & Associates Inc. reduced its stake in Azenta, Inc. (NASDAQ:AZTA) by 0.9% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 79,793 shares of the company’s stock after selling 700 shares during the period. John G Ullman & Associates Inc.’s holdings in Azenta were worth $3,865,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Kayne Anderson Rudnick Investment Management LLC increased its stake in shares of Azenta by 1.9% in the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 5,298,040 shares of the company’s stock worth $278,783,000 after buying an additional 100,826 shares during the period. Dimensional Fund Advisors LP grew its holdings in Azenta by 16.5% in the 2nd quarter. Dimensional Fund Advisors LP now owns 2,970,964 shares of the company’s stock worth $156,331,000 after acquiring an additional 421,719 shares during the last quarter. Allspring Global Investments Holdings LLC increased its position in shares of Azenta by 16.4% in the third quarter. Allspring Global Investments Holdings LLC now owns 1,298,856 shares of the company’s stock valued at $62,917,000 after acquiring an additional 183,040 shares during the period. Royce & Associates LP raised its stake in shares of Azenta by 7.8% during the third quarter. Royce & Associates LP now owns 739,977 shares of the company’s stock valued at $35,844,000 after acquiring an additional 53,584 shares during the last quarter. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Azenta by 3.8% during the second quarter. Bank of New York Mellon Corp now owns 515,393 shares of the company’s stock worth $27,120,000 after purchasing an additional 18,680 shares during the period. Institutional investors own 99.08% of the company’s stock.

Azenta Price Performance

AZTA stock opened at $44.65 on Thursday. Azenta, Inc. has a 1 year low of $38.82 and a 1 year high of $69.16. The firm has a 50-day moving average of $45.32 and a 200 day moving average of $50.22.

Azenta (NASDAQ:AZTA) last announced its earnings results on Tuesday, November 12th. The company reported $0.18 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.10 by $0.08. The firm had revenue of $170.00 million during the quarter, compared to analyst estimates of $169.66 million. Azenta had a positive return on equity of 1.03% and a negative net margin of 25.01%. The business’s revenue was down 1.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.13 EPS. On average, sell-side analysts expect that Azenta, Inc. will post 0.4 EPS for the current fiscal year.

Insiders Place Their Bets

In other Azenta news, Director William L. Cornog bought 12,500 shares of the firm’s stock in a transaction on Monday, November 18th. The stock was acquired at an average price of $39.60 per share, with a total value of $495,000.00. Following the completion of the purchase, the director now owns 14,755 shares of the company’s stock, valued at approximately $584,298. This trade represents a 554.32 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CEO John Marotta bought 12,717 shares of the stock in a transaction dated Monday, November 18th. The shares were acquired at an average price of $39.48 per share, with a total value of $502,067.16. Following the completion of the acquisition, the chief executive officer now directly owns 99,612 shares of the company’s stock, valued at approximately $3,932,681.76. The trade was a 14.63 % increase in their position. The disclosure for this purchase can be found here. 1.77% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of research analysts recently issued reports on AZTA shares. Needham & Company LLC reduced their price target on Azenta from $69.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday, November 13th. Evercore ISI reduced their target price on Azenta from $53.00 to $50.00 and set an “in-line” rating on the stock in a research note on Tuesday, October 1st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus price target of $63.60.

Azenta Profile

Azenta, Inc provides biological and chemical compound sample exploration and management solutions for the life sciences market in North America, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally. The company operates in two reportable segments, Life Sciences Products and Life Sciences Services.